Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

This year’s business critical agenda


Tuesday 9th October

7:30
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:10
Chairman Opening
9:10
-
9:50
CEO panel: The future of care: defining the commercial model for innovation in the Australian market
  • Confront the market access hurdle by adapting to a leaner model for commercialization: leverage new capabilities including value-added services, medical, digital and pharmacy to succeed
  • Better understand the impact of medicines on your patients, their families and community: go beyond your medicines with education, adherence and support to help your patients fulfil their lives
  • How to deliver on our promises: should we explore a new way of funding via outcomes-based results

AbbVie Kirsten O'Doherty GM, ANZ AbbVie

Novo Nordisk Michala Fischer-Hansen VP and GM, ANZ Novo Nordisk

Novartis Oncology Lauren Carey General Manager Novartis Oncology

9:50
-
10:10
Unlocking the potential of precision medicine
  • Understand what is precision medicine, how will it change healthcare in the future and benefit Australian patients
  • What can Australia learn from other countries?
  • Delve into how we can build a national infrastructure to support precision medicine and generate the real-world data
  • Understand the challenges for regulatory and reimbursement bodies in Australia

Janssen Bruce Goodwin Managing Director Janssen

10:10
-
10:30
At the crossroads: can pharma and payers create a sustainable future for both patients and industry?
  • Engage government as a true partner to make the case for win-win reimbursement and speed up access to therapy for patients
  • Major technical innovation is at a new tipping point: how to enable market and payer disruption that works for your strategy
  • The demand for holistic healthcare: how to be part of enabling patients access to services beyond your medicines – including the rare disease perspective

Alexion David Kwasha JAPAC Region Head, Vice President and Managing Director Alexion

10:30
-
11:00
EXHIBITION & NETWORKING COFFEE BREAK
11:00
-
11:35
Panel: Engage and collaborate early with your stakeholders for wider access in everyone’s interests
  • The essential update from Medicines Australia on progress made and new objectives to be met
  • The importance of engaging patients and researchers, alongside government
  • Learn how to build partners to strengthen your case for value
  • Examples of positive results and treatment for patients via compassionate access approval

Rare Cancers Australia Richard Vines CEO Rare Cancers Australia

Shire Brad Edwards General Manager Shire

MSD Nicola Richards Executive Director, Market Access and Policy MSD Australia & New Zealand

Alexion David Kwasha JAPAC Region Head, Vice President and Managing Director Alexion

11:35
-
11:55
Gain approval: fully utilise Therapeutic Goods Administration decision pathways
  • How the priority approval pathway works and the latest insights on whether your medicine might be deemed a priority for Australian patients
  • The new provisional pathway: the key to success and early access. How to judge when early data seems promising
  • Will you receive the approval you hoped for? Where the nuance of wording helps define usage of a new medicine

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

11:55
-
12:15
How to overcome the challenges and changes in market access within Australia
  • An essential briefing on market access and policy changes
  • The requirements for successful RWD for your product development and commercialisation
  • Understand the shift to outcomes: is value-based pricing for you?
  • Break down team silos: speed up your time to market to reach the shared goal of improved patient outcomes

Janssen Duncan O'Brien Executive Director, Integrated Market Access Team Janssen

12:15
-
12:35
An essential update from the PBS
  • Hear from the Department of Health on current reform and policy development.
  • An in-depth conversation discussing change in the Technology Assessment and Access Division

department_of_health_australia Penny Shakespeare Deputy Secretary Department of Health, Australia

12:35
-
12:55
Tactics to speed up time to market
  • Evolving roadblocks to time to market, and what can be done to ensure timely access
  • Updates on policy effecting access, and how this is going to effect the commercial side of the business
  • Case studies on successful patient centric approaches to break down barriers to access

Bayer Pharmaceuticals Matt Slabbert Head of Market Access, Australia & New Zealand Bayer Pharmaceuticals

12:55
-
13:55
EXHIBITION & NETWORKING LUNCH BREAK
13:55
-
14:55
Roundtable Sessions:

Join one of these interactive Roundtable Sessions:

  • Engage HCPS by giving them what they want: work with your customers in order to understand their preferences

Paul White, National Sales Manages- Oncology, Novartis

  • The Google Roundtable: Develop a better internal commercial model to keep up to date with evolving tech

Daniel Webb, Industry Manage, Google

  • Why Embracing Customer Experience is no longer optional

Peter Stephenson, Asia Pacific Digital Transformation Lead, MSD

  • Develop effective content & messaging for customer engagement

Julie Fish, Digital Marketing Manager, Mylan 

  • Can new digital technologies (e.g. VR, interactive 3D animation, AR, VR) support improved health outcomes for healthcare professionals, payers and patients

Donna Bartlett, Program Director, Allori

  • Targeting the Patient Voice: Strategies to involve the patient to inform payer decisions on access to essential innovations in care

Speaker TBC

  • Get the patient Data you need – (PPP) Patient Experience to Preferences to PROMs

Simon Fifer,(Director: Research and Innovation at Community and Patient Preference Research Pty Ltd

  • Patient voices and strategies for access

Speaker TBC

  • The path to patient centricity; strategies for industry to understand the value of the patient voice and create internal support

Hayley Andersen, Head of Patient Advocacy BMS

14:55
-
15:25
How Pfizer are optimising the customer experience for retail pharmacists
  • Improve relationships with pharmacy as an increasingly important stakeholder, to reach your patients for better health outcomes
  • Understand how Pfizer uses an omni-channel approach to create valuable experiences for pharmacists
  • Create meaningful metrics that encourage ongoing improvement

Pfizer Mark Edwards Digital Lead Pfizer

Pfizer Elaine Saad Marketing Lead - Retail Pharmacy Pfizer

15:25
-
15:45
Understand the key contributors to Launch Success
  • An in-depth look at 120 recent launches understand how multifaceted factors such as time to reimbursement determine launch success
  • Delve into launch archetypes with IQVIA to understand common how this provides a common framework for stekhodler about product benefits and forcasting expectations

IQVIA Tom Bryant Senior Principal, Real-World & Analytics Solutions (RWAS) IQVIA

15:45
-
16:05
The Digital Disruption Imperative
  • Understand the characteristics of the companies leading digital disruption - and the key drivers for pharma to get close
  • New trends in patient empowerment that are challenging pharma to address to customer experience imperative
  • Case studies of the latest digital technologies that provide new opportunities for pharma, including virtual reality & virtual assistants and more

MSD Peter Stephenson Asia Pacific Digital Transformation Lead MSD

16:05
-
16:25
Smarter tactics for a nimble digital strategy
  • Invest in results not in process: how to shift from creating assets to driving traffic
  • Discover strategies to speed up content creation and co-create with your audience
  • Engage customers through behavioural profiling local examples on how you can improve your customer strategy
  • Hear how google are developing better internal commercial model to keep up with technology and consumer cycles and what pharma can take-away from this

Google Daniel Webb Industry Manager Google

16:25
-
16:55
EXHIBITION & NETWORKING COFFEE BREAK
16:55
-
17:15
How mobile and social media has changed consumers approach to healthcare
  • Embed a digital approach to communication from mass to targeted.
  • How the development of mobile technology will enhance your ability to create personalised connections and form stronger relationships with your customers
  • Understand what the future of health in a mobile world looks like by exploring how pharma companies are taking a more connected and personal approach to communications; creatively
  • building communities and exploring new brand opportunities

Facebook Dan Sinfield Head of CPG Facebook

17:15
-
17:35
How to win in the changing world of multichannel marketing
  • Understand the evolving multichannel landscape
  • Think differently about your channels to maximize ROI
  • How do you engage HCPs online and know it’s working?
  • PLUS: Best practice, insights and commentary from digital/multichannel leads and brand marketers from Australia’s leading pharma companies

Australian Doctor Group Martha Peacock Commercial Director Australian Doctor Group

17:35
-
17:55
How Aspen launched a cost-effective app for HCP engagement
  • The story of Aspen Xpress - provide HCPs with medical information in their pocket
  • Transform your content into video, audio, text and offline so doctors can access when it suits them
  • Refine and polish for long term use and improved health outcomes

Aspen Richard Clement Group Digital Marketing Manager Aspen

Princeton Health Gavin Walsh General Manager Princeton Health

17:55
-
18:15
Select the right partners for your digital engagement projects to provide the best solutions for your patients
  • Rationale to choose the right vendor, partner, consultant or third party to result in quick deployment, effective engagement and quality UX
  • Key factors to consider in your decision-making process from goals to delivery
  • Differences and considerations between global, regional and local project

Roche Tracey Scrivens Digital Strategy Manager Roche

18:15
-
19:30
EXHIBITION & NETWORKING DRINKS RECEPTION

Wednesday 10th October

8:00
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:20
Do more with less: create a lean commercial model to succeed in Australia
  • Why UCB took the approach to innovate internally, resulting in an integrated commercial model
  • Examine the ecosystem before you redesign your model: what commercial capabilities do you need to thrive?
  • How a lean model can break down siloes in your teams and make adaptation to change easier

UCB Shaun Holmgreen Head, Business Services UCB

9:20
-
10:00
Panel: Align your increasingly complex field force around true customer centricity
  • Harmonize incentives as a key tool in aligning departments
  • Communication is key: work closely to avoid competition for access – and focus on customer value
  • Deploying digital strategies to improve engagement with medical information

Alexion Lynn Sartori Senior Director - Medical Affairs Australia & Asia Alexion

Amicus Therapeutics Simon McErlane Medical Director- Australia & Asia Amicus Therapeutics

Fresenius Kabi Australia Pty Limited Juan Villar Managing Director Fresenius Kabi Australia Pty Limited

10:20
-
10:50
EXHIBITION & NETWORKING COFFEE BREAK
10:50
-
11:10
How big pharma aligned medical, marketing and sales with collaboration
  • How to create common end-to-end goals in both planning and delivery within a large organization
  • Ensure everyone is aligned on the challenges and opportunities in their relevant geography
  • Practical tips on how to build a framework for self-assessment and use shared metrics between your teams

GSK Andrew Weekes Medical Director GSK

11:10
-
11:30
Why you should invest in medical: become a trusted source for your patients
  • Insights from Australia’s first ever MSL survey: gain value for your business and patients
  • The current and future role of MSLs and how this compares to current perceptions
  • Best practices for ensuring top performance of MSLs: how to create a competency framework for hiring and training

APPA Matthew Britland Senior Medical Manager APPA

11:30
-
12:00
Hear the patient’s voice: fireside chat with a Patient Representative
  • A different side to the story: an interactive discussion with a long-term asthma sufferer
  • Understand how you can make a real difference to the quality of life of your patients
  • The importance of programs that go beyond the pill in delivering true long-term value

Novartis Jane Adams Senior Health Economics Manager Novartis

Julia Ovens Asthma Patient

12:00
-
13:30
EXHIBITION & NETWORKING LUNCH BREAK
13:30
-
14:00
How Kidney Australia collaborates with pharma to educate HCPs in order to improve patient support
  • Learn from a benchmark in primary care teaching - how to work together to develop guidelines for HCPs
  • How to form long-term associations that support patients to result in improved outcomes
  • Learn from a patient education program that helped patients with end-stage kidney disease with their difficult decision-making process

Kidney Australia Lisa Murphy Interim CEO Kidney Australia

Amgen Jamal Malik Medical Advisor- Biosimilars & Nephrology Amgen

14:00
-
14:20
How Epilepsy Australia and UCB created a true partnership to deliver value to their patients
  • The process of commencing, developing and continuing pharma-patient partnerships
  • How to build long-term trust with activities initiated together for mutual benefit and positive patient outcomes
  • Examples of effective initiatives, including digital patient education MyEpilepsyKey, HCP solutions and online books for children
  • Hear how patients have benefited from information and resources provided for them

Epilepsy Action Australia Carol Ireland CEO Epilepsy Action Australia

14:20
-
14:55
How will pharma’s supply chain be disrupted in Australia?
  • Is direct distribution the best long-term model for pharma?
  • Is this a strategy for product or portfolio?
  • What’s the key driver for change? Margin or value to the patient?
  • How does direct distribution affect your relationships with partners?

DHL Supply Chain Saul Resnick CEO Australia New Zealand, and Life Science Healthcare APAC DHL Supply Chain

Sigma Healthcare Limited Mark Hooper CEO & Managing Director Sigma Healthcare Limited

The Pharmacy Guild of Australia George Tambassis National President The Pharmacy Guild of Australia

14:55
-
15:15
Brain Health Report - an international collaboration between pharma, neurologists
  • Discover new strategies to co-create education programs to engage the patient
  • Steps taken and lessons learned whilst rolling out an international project across local Australian markets
  • How providing information and education to help with early diagnosis and treatment resulted in improved patient outcomes

MS Australia Deidre Mackechnie CEO MS Australia

15:15
END OF CONFERENCE- COFFEE TO STAY… OR TO GO!

Tuesday 9th October

7:30
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:10
Chairman Opening
9:10
-
9:50
CEO panel: The future of care: defining the commercial model for innovation in the Australian market
  • Confront the market access hurdle by adapting to a leaner model for commercialization: leverage new capabilities including value-added services, medical, digital and pharmacy to succeed
  • Better understand the impact of medicines on your patients, their families and community: go beyond your medicines with education, adherence and support to help your patients fulfil their lives
  • How to deliver on our promises: should we explore a new way of funding via outcomes-based results

AbbVie Kirsten O'Doherty GM, ANZ AbbVie

Novo Nordisk Michala Fischer-Hansen VP and GM, ANZ Novo Nordisk

Novartis Oncology Lauren Carey General Manager Novartis Oncology

9:50
-
10:10
Unlocking the potential of precision medicine
  • Understand what is precision medicine, how will it change healthcare in the future and benefit Australian patients
  • What can Australia learn from other countries?
  • Delve into how we can build a national infrastructure to support precision medicine and generate the real-world data
  • Understand the challenges for regulatory and reimbursement bodies in Australia

Janssen Bruce Goodwin Managing Director Janssen

10:10
-
10:30
At the crossroads: can pharma and payers create a sustainable future for both patients and industry?
  • Engage government as a true partner to make the case for win-win reimbursement and speed up access to therapy for patients
  • Major technical innovation is at a new tipping point: how to enable market and payer disruption that works for your strategy
  • The demand for holistic healthcare: how to be part of enabling patients access to services beyond your medicines – including the rare disease perspective

Alexion David Kwasha JAPAC Region Head, Vice President and Managing Director Alexion

10:30
-
11:00
EXHIBITION & NETWORKING COFFEE BREAK
11:00
-
11:35
Panel: Engage and collaborate early with your stakeholders for wider access in everyone’s interests
  • The essential update from Medicines Australia on progress made and new objectives to be met
  • The importance of engaging patients and researchers, alongside government
  • Learn how to build partners to strengthen your case for value
  • Examples of positive results and treatment for patients via compassionate access approval

Rare Cancers Australia Richard Vines CEO Rare Cancers Australia

Shire Brad Edwards General Manager Shire

MSD Nicola Richards Executive Director, Market Access and Policy MSD Australia & New Zealand

Alexion David Kwasha JAPAC Region Head, Vice President and Managing Director Alexion

11:35
-
11:55
Gain approval: fully utilise Therapeutic Goods Administration decision pathways
  • How the priority approval pathway works and the latest insights on whether your medicine might be deemed a priority for Australian patients
  • The new provisional pathway: the key to success and early access. How to judge when early data seems promising
  • Will you receive the approval you hoped for? Where the nuance of wording helps define usage of a new medicine

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

11:55
-
12:15
How to overcome the challenges and changes in market access within Australia
  • An essential briefing on market access and policy changes
  • The requirements for successful RWD for your product development and commercialisation
  • Understand the shift to outcomes: is value-based pricing for you?
  • Break down team silos: speed up your time to market to reach the shared goal of improved patient outcomes

Janssen Duncan O'Brien Executive Director, Integrated Market Access Team Janssen

12:15
-
12:35
An essential update from the PBS
  • Hear from the Department of Health on current reform and policy development.
  • An in-depth conversation discussing change in the Technology Assessment and Access Division

department_of_health_australia Penny Shakespeare Deputy Secretary Department of Health, Australia

12:35
-
12:55
Tactics to speed up time to market
  • Evolving roadblocks to time to market, and what can be done to ensure timely access
  • Updates on policy effecting access, and how this is going to effect the commercial side of the business
  • Case studies on successful patient centric approaches to break down barriers to access

Bayer Pharmaceuticals Matt Slabbert Head of Market Access, Australia & New Zealand Bayer Pharmaceuticals

12:55
-
13:55
EXHIBITION & NETWORKING LUNCH BREAK
13:55
-
14:55
Roundtable Sessions:

Join one of these interactive Roundtable Sessions:

  • Engage HCPS by giving them what they want: work with your customers in order to understand their preferences

Paul White, National Sales Manages- Oncology, Novartis

  • The Google Roundtable: Develop a better internal commercial model to keep up to date with evolving tech

Daniel Webb, Industry Manage, Google

  • Why Embracing Customer Experience is no longer optional

Peter Stephenson, Asia Pacific Digital Transformation Lead, MSD

  • Develop effective content & messaging for customer engagement

Julie Fish, Digital Marketing Manager, Mylan 

  • Can new digital technologies (e.g. VR, interactive 3D animation, AR, VR) support improved health outcomes for healthcare professionals, payers and patients

Donna Bartlett, Program Director, Allori

  • Targeting the Patient Voice: Strategies to involve the patient to inform payer decisions on access to essential innovations in care

Speaker TBC

  • Get the patient Data you need – (PPP) Patient Experience to Preferences to PROMs

Simon Fifer,(Director: Research and Innovation at Community and Patient Preference Research Pty Ltd

  • Patient voices and strategies for access

Speaker TBC

  • The path to patient centricity; strategies for industry to understand the value of the patient voice and create internal support

Hayley Andersen, Head of Patient Advocacy BMS

14:55
-
15:25
How Pfizer are optimising the customer experience for retail pharmacists
  • Improve relationships with pharmacy as an increasingly important stakeholder, to reach your patients for better health outcomes
  • Understand how Pfizer uses an omni-channel approach to create valuable experiences for pharmacists
  • Create meaningful metrics that encourage ongoing improvement

Pfizer Mark Edwards Digital Lead Pfizer

Pfizer Elaine Saad Marketing Lead - Retail Pharmacy Pfizer

15:25
-
15:45
Understand the key contributors to Launch Success
  • An in-depth look at 120 recent launches understand how multifaceted factors such as time to reimbursement determine launch success
  • Delve into launch archetypes with IQVIA to understand common how this provides a common framework for stekhodler about product benefits and forcasting expectations

IQVIA Tom Bryant Senior Principal, Real-World & Analytics Solutions (RWAS) IQVIA

15:45
-
16:05
The Digital Disruption Imperative
  • Understand the characteristics of the companies leading digital disruption - and the key drivers for pharma to get close
  • New trends in patient empowerment that are challenging pharma to address to customer experience imperative
  • Case studies of the latest digital technologies that provide new opportunities for pharma, including virtual reality & virtual assistants and more

MSD Peter Stephenson Asia Pacific Digital Transformation Lead MSD

16:05
-
16:25
Smarter tactics for a nimble digital strategy
  • Invest in results not in process: how to shift from creating assets to driving traffic
  • Discover strategies to speed up content creation and co-create with your audience
  • Engage customers through behavioural profiling local examples on how you can improve your customer strategy
  • Hear how google are developing better internal commercial model to keep up with technology and consumer cycles and what pharma can take-away from this

Google Daniel Webb Industry Manager Google

16:25
-
16:55
EXHIBITION & NETWORKING COFFEE BREAK
16:55
-
17:15
How mobile and social media has changed consumers approach to healthcare
  • Embed a digital approach to communication from mass to targeted.
  • How the development of mobile technology will enhance your ability to create personalised connections and form stronger relationships with your customers
  • Understand what the future of health in a mobile world looks like by exploring how pharma companies are taking a more connected and personal approach to communications; creatively
  • building communities and exploring new brand opportunities

Facebook Dan Sinfield Head of CPG Facebook

17:15
-
17:35
How to win in the changing world of multichannel marketing
  • Understand the evolving multichannel landscape
  • Think differently about your channels to maximize ROI
  • How do you engage HCPs online and know it’s working?
  • PLUS: Best practice, insights and commentary from digital/multichannel leads and brand marketers from Australia’s leading pharma companies

Australian Doctor Group Martha Peacock Commercial Director Australian Doctor Group

17:35
-
17:55
How Aspen launched a cost-effective app for HCP engagement
  • The story of Aspen Xpress - provide HCPs with medical information in their pocket
  • Transform your content into video, audio, text and offline so doctors can access when it suits them
  • Refine and polish for long term use and improved health outcomes

Aspen Richard Clement Group Digital Marketing Manager Aspen

Princeton Health Gavin Walsh General Manager Princeton Health

17:55
-
18:15
Select the right partners for your digital engagement projects to provide the best solutions for your patients
  • Rationale to choose the right vendor, partner, consultant or third party to result in quick deployment, effective engagement and quality UX
  • Key factors to consider in your decision-making process from goals to delivery
  • Differences and considerations between global, regional and local project

Roche Tracey Scrivens Digital Strategy Manager Roche

18:15
-
19:30
EXHIBITION & NETWORKING DRINKS RECEPTION

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Wednesday 10th October

8:00
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:20
Do more with less: create a lean commercial model to succeed in Australia
  • Why UCB took the approach to innovate internally, resulting in an integrated commercial model
  • Examine the ecosystem before you redesign your model: what commercial capabilities do you need to thrive?
  • How a lean model can break down siloes in your teams and make adaptation to change easier

UCB Shaun Holmgreen Head, Business Services UCB

9:20
-
10:00
Panel: Align your increasingly complex field force around true customer centricity
  • Harmonize incentives as a key tool in aligning departments
  • Communication is key: work closely to avoid competition for access – and focus on customer value
  • Deploying digital strategies to improve engagement with medical information

Alexion Lynn Sartori Senior Director - Medical Affairs Australia & Asia Alexion

Amicus Therapeutics Simon McErlane Medical Director- Australia & Asia Amicus Therapeutics

Fresenius Kabi Australia Pty Limited Juan Villar Managing Director Fresenius Kabi Australia Pty Limited

10:20
-
10:50
EXHIBITION & NETWORKING COFFEE BREAK
10:50
-
11:10
How big pharma aligned medical, marketing and sales with collaboration
  • How to create common end-to-end goals in both planning and delivery within a large organization
  • Ensure everyone is aligned on the challenges and opportunities in their relevant geography
  • Practical tips on how to build a framework for self-assessment and use shared metrics between your teams

GSK Andrew Weekes Medical Director GSK

11:10
-
11:30
Why you should invest in medical: become a trusted source for your patients
  • Insights from Australia’s first ever MSL survey: gain value for your business and patients
  • The current and future role of MSLs and how this compares to current perceptions
  • Best practices for ensuring top performance of MSLs: how to create a competency framework for hiring and training

APPA Matthew Britland Senior Medical Manager APPA

11:30
-
12:00
Hear the patient’s voice: fireside chat with a Patient Representative
  • A different side to the story: an interactive discussion with a long-term asthma sufferer
  • Understand how you can make a real difference to the quality of life of your patients
  • The importance of programs that go beyond the pill in delivering true long-term value

Novartis Jane Adams Senior Health Economics Manager Novartis

Julia Ovens Asthma Patient

12:00
-
13:30
EXHIBITION & NETWORKING LUNCH BREAK
13:30
-
14:00
How Kidney Australia collaborates with pharma to educate HCPs in order to improve patient support
  • Learn from a benchmark in primary care teaching - how to work together to develop guidelines for HCPs
  • How to form long-term associations that support patients to result in improved outcomes
  • Learn from a patient education program that helped patients with end-stage kidney disease with their difficult decision-making process

Kidney Australia Lisa Murphy Interim CEO Kidney Australia

Amgen Jamal Malik Medical Advisor- Biosimilars & Nephrology Amgen

14:00
-
14:20
How Epilepsy Australia and UCB created a true partnership to deliver value to their patients
  • The process of commencing, developing and continuing pharma-patient partnerships
  • How to build long-term trust with activities initiated together for mutual benefit and positive patient outcomes
  • Examples of effective initiatives, including digital patient education MyEpilepsyKey, HCP solutions and online books for children
  • Hear how patients have benefited from information and resources provided for them

Epilepsy Action Australia Carol Ireland CEO Epilepsy Action Australia

14:20
-
14:55
How will pharma’s supply chain be disrupted in Australia?
  • Is direct distribution the best long-term model for pharma?
  • Is this a strategy for product or portfolio?
  • What’s the key driver for change? Margin or value to the patient?
  • How does direct distribution affect your relationships with partners?

DHL Supply Chain Saul Resnick CEO Australia New Zealand, and Life Science Healthcare APAC DHL Supply Chain

Sigma Healthcare Limited Mark Hooper CEO & Managing Director Sigma Healthcare Limited

The Pharmacy Guild of Australia George Tambassis National President The Pharmacy Guild of Australia

14:55
-
15:15
Brain Health Report - an international collaboration between pharma, neurologists
  • Discover new strategies to co-create education programs to engage the patient
  • Steps taken and lessons learned whilst rolling out an international project across local Australian markets
  • How providing information and education to help with early diagnosis and treatment resulted in improved patient outcomes

MS Australia Deidre Mackechnie CEO MS Australia

15:15
END OF CONFERENCE- COFFEE TO STAY… OR TO GO!

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription